GSK Investigational Site

Barretos, São Paulo 14784-400

1 studies enrolling now · 3 studies all time

What they study most

Gastrointestinal Neoplasms, Lung Cancer, Non-Small Cell, Neoplasms, Head and Neck

Studies at this site

• A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy — Recruiting now
• Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 (PD-L1) Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma — Stopped early
• GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer — Stopped early